Features of Atrial Fibrillation in Patients with Arterial Hypertension and Extracardial Disorders

被引:1
|
作者
Khidirova, Lyudmila D. [1 ]
Yakhontov, David A. [1 ]
Zenin, Sergei A. [2 ]
Mamedov, Mehman N. [3 ]
机构
[1] Novosibirsk State Med Univ, Chair Pharmacol Clin Pharmacol & Evidence Based M, Krasny Prosp 52, Novosibirsk 630091, Russia
[2] Novosibirsk Reg Clin Cardiol Dispensary, Dept Surg Treatment Complex Cardiac Arrhythmias &, Zalesskogo Ul 6-8, Novosibirsk 630047, Russia
[3] Natl Med Res Ctr Prevent Med, Lab Interdisciplinary Approach Prevent Chron Nonc, Petroverigsky Per 10, Moscow 101990, Russia
关键词
atrial fibrillation; arterial hypertension; diabetes mellitus; obesity; thyroid gland; chronic obstructive pulmonary disease; PROGRESSION; PRESSURE; OBESITY;
D O I
10.20996/1819-6446-2019-15-3-368-373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study the features of the progression of atrial fibrillation (AF) in patients with arterial hypertension (HT) and comorbid extracardiac diseases. Material and methods. In the observational cohort study 308 men 45-65 years old with AF and HT were observed Most patients also had the following comorbid extracardiac diseases: diabetes mellitus (DM; n=40), diffuse toxic goiter (DTG; n=42); hypothyroidism (HTH; n=59), abdominal obesity (AO; n=64), and chronic obstructive pulmonary disease (COPD; n=47). The comparison group consisted of 56 patients with AF and HT only. Clinical, anthropometric, laboratory parameters, levels of NT-proBNP and galectin-3, results of ECG, daily monitoring of ECG and blood pressure were assessed initially and after 12 months. Results. Persistent AF (29.6-65.2%) and long-term persistent AF (16-31.3%) were more common in groups with extracardiac diseases compared with the AF+HT group (20.4% and 14.2%, respectively). Permanent form of AF was statistically significantly more common in the DM (11.1%), AO (14.8%) and HTH (6.2%) groups compared with the AF+HT group (0.6%). A comparative assessment of risk factors (smoking and alcohol) did not show significant differences in prevalence in the groups (22-44%). An assessment of the levels of fibrosis and remodeling markers found a statistically significant increase in the level of galectin-3 in groups of patients with concomitant extracardiac diseases and an increase in the NT-proBNP level, relative to reference values in all groups except DTG. Conclusion. Patients with AF in combination with HT and comorbid extracardiac diseases have a more rapid AF progression.
引用
收藏
页码:368 / 373
页数:6
相关论文
共 50 条
  • [31] Role of obesity and hypertension in the incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
    La Sala, Lucia
    Pontiroli, Antonio E.
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [32] Role of obesity and hypertension in the incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
    Lucia La Sala
    Antonio E. Pontiroli
    Cardiovascular Diabetology, 20
  • [33] Management of atrial fibrillation in patients with hypertension
    Kowey, PR
    Marinchak, RA
    Rials, SJ
    Filart, RA
    JOURNAL OF HUMAN HYPERTENSION, 1997, 11 (11) : 699 - 707
  • [34] Management of atrial fibrillation in patients with hypertension
    PR Kowey
    RA Marinchak
    SJ Rials
    RA Filart
    Journal of Human Hypertension, 1997, 11 : 699 - 707
  • [35] Arterial hypertension and atrial fibrillation: standard and advanced echocardiography from diagnosis to prognostication
    Cameli, Matteo
    Mandoli, Giulia E.
    Ambrosio, Giuseppe
    Cerbai, Elisabetta
    Coiro, Stefano
    Emdin, Michele
    Marcucci, Rossella
    Morrone, Doralisa
    Palazzuoli, Alberto
    Savino, Ketty
    Padeletti, Luigi
    Mondillo, Sergio
    Pedrinelli, Roberto
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2018, 19 (02) : 51 - 61
  • [36] ELECTROPHYSIOLOGICAL CARDIAC PARAMETERS AND RESULTS OF ANTIARRHYTHMIC TREATMENT IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION (LONE AND ASSOCIATED WITH ARTERIAL HYPERTENSION)
    Mironova, E. S.
    Mironov, N. Yu.
    Mironova, N. A.
    Novikov, P. S.
    Novikov, I. A.
    Laiovich, L. Yu.
    Maikov, E. B.
    Golitsyn, S. P.
    KARDIOLOGIYA, 2019, 59 (08) : 39 - 46
  • [37] Risk of atrial fibrillation in endometrial cancer patients
    Munzova, D.
    Bretova, P.
    Pesl, M.
    Weinberger, V.
    Minar, L.
    Felsinger, M.
    CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY, 2024, 89 (06): : 439 - 444
  • [38] The prevalence of sleep breathing disorders in patients with atrial fibrillation undergoing catheter treatment
    Agaltsov, Mihail V.
    Drapkina, Oxana M.
    Davtyan, Karapet V.
    Arutyunyan, Grair G.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2019, 15 (01) : 36 - 42
  • [39] IC Class medications in patients with atrial fibrillation, arterial hypertension, chronic heart failure and intact systolic function
    Miller, O. N.
    Skurikhina, O. N.
    Starichkov, S. A.
    RUSSIAN JOURNAL OF CARDIOLOGY, 2008, (04): : 25 - 33
  • [40] Treatment of Arterial Hypertension in Obese Patients
    Wenzel, Ulrich O.
    Benndorf, Ralf
    Lange, Sascha
    SEMINARS IN NEPHROLOGY, 2013, 33 (01) : 66 - 74